TGA releases second discussion paper: Improving access to CMI and PI
15 February 2007
Note: This consultation closed on 30 March 2007.
In April 2005, the Therapeutic Goods Administration (TGA) released a Discussion Paper on the most appropriate means for improving consumer and professional access to web based copies of up-to-date Consumer Medicine Information (CMI) and Product Information (PI).
Following the release of the Initial Discussion Paper, the TGA held forums in Sydney and Melbourne to discuss the issues raised in the paper and to seek stakeholder view on options for improving consumer and professional access to web based copies of up-to-date CMI and PI. Written submissions were also received from a wide range of stakeholders.
As a result of the very valuable feedback provided on the Initial Discussion Paper, the TGA is now able to provide more detail about each of the options discussed and report on the outcome of the consultations.
The purpose of this Second Discussion Paper is to seek stakeholder views on some revised options including the TGA’s preferred option. As the feedback from this consultation will also flow through into the development of practices for Australia New Zealand Therapeutic Products Authority (ANZTPA) and the joint regulatory scheme, feed back is sought from both New Zealand and Australian stakeholders.
The Second Discussion Paper is now available on the TGA website.
URL: http://www.anztpa.org/pm/accesspmi2.htm

